What Global Pharmacovigilance Database Interoperability & Data Sharing (2026) requires
Regulatory requirements for the electronic exchange of pharmacovigilance information, specifically Individual Case Safety Reports (ICSRs), between pharmaceutical companies, national regulators, and global databases (e.g., EudraVigilance, WHO VigiBase) using the ICH E2B(R3) standard.
Pillar: Medical & Healthcare · Authority: International Council for Harmonisation (ICH) & European Medicines Agency (EMA) · Version: 1.0.0 · Last updated:
Primary source: https://www.ema.europa.eu/en/human-regulatory/research-development/pharmacovigilance/eudravigilance
SHA-256 integrity: 5bea7edd73b4c3bf5fa6e87f87ccbd4c0c3ba8ec2d60e1ded9f7a35d6b698377
Primary Citations — 2 traced to source
- ICH E2B(R3) Electronic Transmission of Individual Case Safety Reports (ICSRs)
- EMA Guideline on good pharmacovigilance practices (GVP) Module VI
Access
- Discovery (free): /api/v1/nodes/global-pharmacovigilance-database-interoperability-2026.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/global-pharmacovigilance-database-interoperability-2026.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/global-pharmacovigilance-database-interoperability-2026
- Back to registry: Browse all 10,085 compliance nodes